FHOD1 and breast carcinoma: For instance, miR-200 was shown to target cytoskeleton remodeling proteins in breast cancer cells, including WASF3, Moesin, FHOD1, PPM1F, WIPF1 and Cofilin2, functional mediators of miR-200 in the suppression of invasion and/or metastasis [8–12].